Sanofi resolves most Zantac litigation
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hey! Meghana here. Today, we’re encouraging you to look elsewhere within the STAT universe for fantastic content. There’s, of course, our podcast, “The Readout Loud,” and Adam Feuerstein’s spicy new newsletter, “Adam’s Biotech Scorecard.” We’ll also be reporting from the annual meeting of the American College of Cardiology this weekend. You can sign up for ACC in 30 Seconds here.
Read Original Article: Sanofi resolves most Zantac litigation »
